Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/24/15 → 3/24/18 |
Funding
- Duke Clinical Research Institute (GS-US-218-0108 // GS-US-218-0108)
- Gilead Sciences, Inc (GS-US-218-0108 // GS-US-218-0108)
GS-US-218-0108, “A Phase 2b, Randomized, Double-Blind, A Phase 2b, Randomized, Double-Blind, Placebo Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS 5806 in Hematopoietic Cell Transplant (HCT) R
- Ison, Michael G (PD/PI)
Project: Research project